Results 211 to 220 of about 15,568 (286)
Cytokines and chemokines in Mycobacterium tuberculosis infection [PDF]
Cooper, Andrea +3 more
core +2 more sources
One‐carbon metabolism (OCM) nutrients play a critical role in fetal development and are implicated in the etiology of spontaneous pregnancy loss (SPL). In our large cohort study, we report for the first time that paternal red blood cell folate levels ≥ 400 ng/mL—consistent with the World Health Organization's recommendation for neural tube defect ...
Xiaotian Chen +18 more
wiley +1 more source
Improving access to gene therapy for rare diseases
Thomas A. Fox, Claire Booth
doaj +1 more source
Gastroenterological disorders in inborn errors of immunity. Part 1. Epidemiology, classification, symptoms, diagnosis, and treatment. [PDF]
Napiórkowska-Baran K +7 more
europepmc +1 more source
Malignancies in the inborn errors of immunity
Ekaterini Simões Goudouris +3 more
openaire +2 more sources
Lymphatic topology reveals a novel intranodal lympho‐venous shunt
Abstract Understanding the lymphatic network is crucial for immunological research. Currently, a complete map of lymphatic drainage in mice is lacking. We present a detailed lymphatic system flow dynamic of two mouse strains with swollen lymph nodes (LNs), using region‐specific tracer injection and high‐resolution micro‐CT imaging to characterize LN ...
Ariunbuyan Sukhbaatar +5 more
wiley +1 more source
Malignancy and Autoimmune Susceptibility in Adult Patients with Human Inborn Errors of Immunity. [PDF]
Segura-Tudela A +10 more
europepmc +1 more source
The Potential of Digital Twins for Pediatric Rare Diseases
ABSTRACT Rare diseases affect over 300 million people globally, with approximately 75% manifesting in childhood. Their diagnosis is often delayed and approved treatments are lacking for most of the conditions. Pediatric rare diseases research is further complicated by ethical constraints and developmental diversity across childhood.
Rahuman S. Malik‐Sheriff +4 more
wiley +1 more source
Objectives To evaluate the efficacy and safety of a fixed‐dose combination (FDC) of dutasteride and tadalafil vs monotherapy in patients with benign prostatic hyperplasia (BPH). Patients and Methods This phase III trial enrolled 667 patients. After screening and washout, eligible patients were stratified by the baseline International Prostate Symptom ...
Seung Wook Lee +20 more
wiley +1 more source

